S J. Talks - Publications

Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD study.

Journal: Eye (London, England)

Published: April 07, 2025

The Patient Voice in Neovascular Age-Related Macular Degeneration: Findings from a Qualitative Study.

Journal: Ophthalmology and therapy

Published: October 27, 2022

Aflibercept in clinical practice; visual acuity, injection numbers and adherence to treatment, for diabetic macular oedema in 21 UK hospitals over 3 years.

Journal: Eye (London, England)

Published: February 20, 2021

Delayed follow-up of medical retina patients due to COVID-19: impact on disease activity and visual acuity.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: January 22, 2021

Macula service evaluation and assessing priorities for anti-VEGF treatment in the light of COVID-19.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: May 08, 2020

Expanding the role of medical retina virtual clinics using multimodal ultra-widefield and optical coherence tomography imaging.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: December 12, 2018

Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab.

Journal: Eye (London, England)

Published: June 20, 2018

The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration.

Journal: Survey of ophthalmology

Published: December 20, 2017

First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration.

Journal: Ophthalmology

Published: June 26, 2015